About Sodium Strach Glycolate (Maize & Potato)
Sodium Strach Glycolate (Maize & Potato)
CAS Number : 9063-38-1
Molecular Formula : C24H44O6NA
Application : Sodium starch glycolate is widely used in oral pharmaceuticals as a disintegrant in capsule and tablet formulations. It is recommended to use in tablets prepared by either directcompression or wet-granulation processes.
Superior Tablet DisintegrationSodium Starch Glycolate ensures quick and effective disintegration of tablets and capsules, thanks to its remarkable water absorption and swelling properties. This accelerates the release and absorption of active pharmaceutical ingredients, promoting uniform efficacy. Its amorphous, free-flowing powder form enables precise formulation blending and enhanced manufacturing efficiency for pharmaceutical companies.
Strict Quality and Compliance StandardsMeeting or exceeding all major pharmacopeial requirements (IP/BP/USP), Sodium Starch Glycolate offers guaranteed safety and performance. Every batch undergoes meticulous quality checks for purity, heavy metals, microbial content, and physical properties. This careful control reassures manufacturers, distributors, and healthcare professionals of consistent, high-quality outcomes in finished dosage forms.
Versatile Sourcing and Global ReachAvailable as maize- or potato-derived forms, Sodium Starch Glycolate can be sourced and supplied to pharmaceutical manufacturers worldwide. Recognized under CAS No. 9063-38-1 and HS Code 350510, it is distributed in 25kg HDPE drums with protective liners, ensuring product integrity from factory to end user across India and internationally.
FAQs of Sodium Strach Glycolate (Maize & Potato):
Q: How is Sodium Starch Glycolate used in pharmaceutical formulations?
A: Sodium Starch Glycolate is primarily employed as a super disintegrant in tablet and capsule preparations. Its rapid swelling upon water absorption helps dissolve the dosage form quickly, allowing for more efficient drug release and absorption in the body.
Q: What are the recommended usage concentrations for Sodium Starch Glycolate?
A: The suggested concentration for Sodium Starch Glycolate in oral pharmaceutical formulations is typically between 2% and 8%. The exact dosage may vary depending on the type of formulation and the desired disintegration profile.
Q: When should Sodium Starch Glycolate be stored and what precautions should be taken?
A: This product should be stored in a cool, dry place and kept in a tightly closed container to maintain quality and efficacy. Avoid exposure to moisture and direct sunlight to preserve its free-flowing and swelling characteristics.
Q: Where is Sodium Starch Glycolate sourced from and in what forms is it available?
A: Sodium Starch Glycolate can be derived from either maize or potato starch. Both variants are offered in the same pharmaceutical grade, complying with international regulatory standards and suitable for various formulation needs.
Q: What is the major benefit of using Sodium Starch Glycolate in tablet manufacturing?
A: Its major advantage lies in promoting rapid disintegration, ensuring that the active pharmaceutical ingredient is released promptly for absorption, ultimately improving therapeutic effectiveness and patient compliance.
Q: What processes are involved in ensuring the quality of Sodium Starch Glycolate?
A: Quality assurance includes strict testing for purity (minimum 98%), microbial limits, heavy metal content, physical properties, and compliance with pharmacopeial standards (IP/BP/USP) to verify it meets safety and functionality requirements.
Q: How does Sodium Starch Glycolate comply with regulatory and safety standards?
A: This excipient meets the specifications set by the IP, BP, and USP. It is tested for permissible levels of impurities, heavy metals (not exceeding 20 ppm), and controlled microbial content, and is considered non-poisonous, safe, and effective for pharmaceutical use.